Article
CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis.
Journal of neuroimmunology - 1 Jul 2003
van Veen Tineke, Crusius J Bart A, van Winsen Lisa, Xia Bing, Barkhof Frederik, Salvador Peña A, Polman Chris H, Uitdehaag Bernard M J
Abstract excerpt
The balance between CD28 and CTLA-4 signalling is important for regulation of the immune response. We were interested whether a genetically mediated disturbance of this balance could be related to susceptibility or severity of multiple sclerosis (MS). We examined three polymorphisms in these genes, CTLA-4-318, CTLA-4+49 and CD28-I3+17, in 514 patients with MS and 181 controls. As the loci cannot be assumed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
